Chronic toxic and carcinogenic effects of oral cadmium in the noble (nbl/cr) rat: Induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes

Journal of Toxicology and Environmental Health - Part A

Volumn 58, Issue 4, 1999, Pages 199-214

  Waalkes, Michael P ^a   Anver, Miriam R ^b   Diwan, Bhalchandra A ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CADMIUM CHLORIDE;

ADRENAL CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL HYPERPLASIA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOSE RESPONSE; HEPATITIS; KIDNEY CANCER; LEYDIG CELL; LUNG CANCER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROSTATE CANCER; RAT; SPECIES DIFFERENCE; SPLEEN DISEASE; TESTIS CANCER; TESTIS FUNCTION;

ADRENAL GLAND NEOPLASMS; ANIMALS; CADMIUM; CARCINOGENICITY TESTS; CARCINOGENS; HEPATITIS, TOXIC; HYPERPLASIA; KIDNEY NEOPLASMS; MALE; PHEOCHROMOCYTOMA; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS; SPLENIC DISEASES; TESTICULAR NEOPLASMS;

ANIMALIA; RATTUS NORVEGICUS; RODENTIA;

EID: 0033615560     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841099157296     Document Type: Article

References (46)

1. Bosland, M. C. 1994. Male reproductive system. In Target organ toxicology; Carcinogenesis, eds. M. P. Waalkes and J. M. Ward, pp. 339-401. New York: Raven Press.
2. Bosland, M. C. 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog. Clin. Biol. Res.394:309-352.
3. Coffey, D. S., and Isaacs, J. T. 1981. Control of prostate growth. Urology3:17-24.
4. Diwan, B. A., Ohshima, M., and Rice, J. M. 1989. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)-nitrosamine, and the lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors. Carcinogenesis10:183-188.
5. Diwan, B. A., Kasprzak, K. S., and Rice, J. M. 1992. Transplacental carcinogenic effects of Ni(II) in the renal cortex, renal pelvis and adenohypophysis in F344/NCr rats. Carcinogenesis13:1351-1357.
6. Diwan, B. A., Anderson, L. M., Ward, J. M., Henneman, J. R., and Rice, J. M. 1995. Transplacental carcinogenesis by cisplatin in F344/NCr rats: Promotion of kidney tumors by postnatal administration of sodium barbital. Toxicol. Appl. Pharmacol.133:115-121.
7. Elghany, N. A., Schumacher, M. C., Slattery, M. L., West, D. W., and Lee, J. S. 1990. Occupation, cadmium exposure and prostate cancer. Epidemiology1: 107-115.
8. Fort, F. L., Miyajima, H., Suzuki, T., Yamamoto, M., Hamashima, T., Sato, S., Kitazaki, T., Mahony, M. C., and Hogden, G. D. 1995. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fundam. Appl. Toxicol.26:191-202.
9. Garcia Sanchez, A., Antona, J. F., and Urrutia, M. 1992. Geochemical prospection of cadmium in a high incidence area of prostate cancer, Serra de Gata, Salamanca, Spain. Sci. Total Environ. 116:243-251.
10. Hiasa, Y., and Ito, N. 1987. Experimental induction of renal tumors. CRC Crit. Rev. Toxicol.17:279-343.
11. IARC. 1987. Overall evaluation of carcinogenicity: An updating of IARC monographs volume 1-42. IARCMonogr. Suppl.7:230-232.
12. IARC. 1993. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. IARC Monogr.58:119-238.
13. Kasprzak, K. S., Diwan, B. A., Konishi, N., Misra, M., and Rice, J. M. 1990. Initiation by nickel acetate and promotion by sodium barbital of renal cortical epithelial tumors in male F344/NCr rats. Carcinogenesis11:647-652.
14. Key, T. 1995. Risk factors for prostate cancer. CancerSur.23:63-77.
15. Klaassen, C. D., and Liu, J. 1997. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab. Rev.29:79-102.
16. Kolonel, L. N. 1976. Association of cadmium with renal prostate cancer. Cancer37:1782-1787.
17. Kolonel, L. N. 1996. Nutrition and prostate cancer. Cancer Causes Control7:83-94.
18. Mandel, J. S., McLaughlin, J. K., Schlehofer, B., Mellemgaard, A., Helmert, U., Linblad, P., McCredie, M., and Adami, U. 1995. International renal-cell cancer study. IV. Occupation. Int. J. Cancer61:601-605.
19. Mettlin, C. 1997. Recent developments in the epidemiology of prostate cancer. Eur. J. Cancer33:340-347.
20. Murakami, M., Hosokawa, S., Yamada, T., Harayawa, M., Ito, M., Koyama, Y., Kimura, J., Yoshitake, A., and Yamada, H. 1995. Species-specific mechanism in rat Leydig cell tumorigenesis by procymi-done. Toxicol. Appl. Pharmacol.131:244-252.
21. Nobel, R. L. 1977. The development of prostatic adenocarcinomas in Nb rats following prolonged sex hormone administration. Cancer Res.37:1929-1933.
22. Noble, R. L. 1982. Prostate carcinoma of the Nb rat in relation to hormones. Int. Rev. Exp. Pathol. 23:113-159.
23. Oishi, K., Yoshida, O., and Schroeder, F. Z. 1995. The geography of prostate cancer and its treatment in Japan. Cancer Surveys23:267-280.
24. Price, D. 1963. Comparative aspects of development and structure in the prostate. Monogr. Natl. Cancer Inst.12:1-25.
25. Roberts, S. A., Nett, T. M., Hartman, H. A., Adams, T. E., and Stoll, R. E. 1989. SDZ 200-11 0 induces Leydig cell tumors by increasing gonadotropins in rats. J. Am. Coll. Toxicol.8:487-505.
26. Shirai, T., Ohshima, M., Masuda, A., Tamano, S., and Ito, N. 1984. Promotion of 2-(ethyl nitro-samino)ethanol-induced renal carcinogenesis in rats by nephrotic compounds: Positive responses with folic acid, basic lead acetate, and N-(3,5-dichlorophenyl)succinimide but not with 2,3-dibromo-1 -propanol-phosphate. J. Natl. Cancer Inst.72:477-481.
27. Shirai, T., Iwasaki, S., Masui, T., Mori, T., Kato, T., and Ito, N. 1993. Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res.84:1023-1030.
28. Shiraishi, N., and Waalkes, M. P. 1996. Acquired tolerance to cadmium-induced toxicity in the rodent testes. Toxic Subst. Mech.15:27-42.
29. Slayter, M. V., Anzano, M. A., Kadomatsu, K., Smith, J. M., and Sporn, M. B. 1994. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: A system for histological scoring and grading. Cancer Res.54:1440-1445.
30. Tanner, D. C., and Lipsky, M. M. 1984. Effect of lead acetate on N-(4'-fluor-4-biphenyl)acetamide-induced renal carcinogenesis in the rat. Carcinogenesis5:1109-1113.
31. Waalkes, M. P. 1995. Cadmium and carcinogenesis. In Handbook on metal-ligand interactions of biological fluids, Vol. 2, ed. G. Berthan, pp. 471-482. New York: Marcel Dekker.
32. Waalkes, M. P., and Misra, R. R. 1996. Cadmium carcinogenicity and genotoxicity. In Toxicology of metals, ed. L. W. Chang, pp. 231-244. Boca Raton, FL: CRC Press.
33. Waalkes, M. P., and Rehm, S. 1992. Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: Effect of chronic dietary zinc deficiency. Fundam. Appl. Toxicol.19:512-520.
34. Waalkes, M. P., and Rehm, S. 1994. Cadmium and prostate cancer. J. Toxicol. Environ. Health43:251-269.
35. Waalkes, M. P., and Rehm, S. 1995. Carcinogenic and chronic toxic effects of single or multiple subcutaneous doses of cadmium chloride in male Swiss [CR:NIH(S)] mice. Toxic Subst. Mech. 14:79-92.
36. Waalkes, M. P., Rehm, S., Riggs, C. W., Bare, R. M., Devor, D. E., Poirier, L. A., Wenk, M. L., Henneman, J. R., and Balaschak, M. S. 1988. Cadmium carcinogenesis i n male Wistar [Crl:(WI)BR] rats: Dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res.48:4656-4663.
37. Waalkes, M. P., Rehm, S., Riggs, C. W., Bare, R. M., Devor, D. E., Poirier, L. A., Wenk, M. L., and Henneman, J. R. 1989. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res.49:4282-4288.
38. Waalkes, M. P., Rehm, S., Sass, B., Konishi, N., Bare, R. M., and Ward, J. M. 1991. Chronic carcinogenic and toxic effects of a single subcutaneous dose of cadmium in the male Fischer rat. Environ. Res.55:40-50.
39. Waalkes, M. P., Rehm, S., Sass, B., Kovatch, R., and Ward, J. M. 1994. Chronic carcinogenesis and toxic effects of a single subcutaneous dose of cadmium in male NFS and C57 mice and male Syrian hamsters. Toxic Subst. J.13:15-28.
40. Waalkes, M. P., Diwan, B. A., Ward, J. M., Devor, D. E., and Goyer, R. M. 1995. Renal tubular tumors and atypical hyperplasias in B6C3F mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer Res.55:5265-5271.
41. Waalkes, M. P., Rehm, S., Coogan, T. P., and Ward, J. M. 1997a. Role of cadmium in the etiology cancer of the prostate. In Target organ toxicology series: Endocrine toxicology, eds. J. A. Thomas and H. D. Colby, pp. 277-244. New York: Raven Press.
42. Waalkes, M. P., Rehm, S., and Devor, D. E. 1997b. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: Loss of testicular response. Toxicol. Appl. Pharmacol.142:40-46.
43. Waalkes, M. P., Anver, M., and Diwan, B. A. 1999. Carcinogenic effects of cadmium in the Noble (NBL/Cr) rat: Induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative l esions of the dorsolateral prostate. Toxicol. Sci., in press.
44. West, D. W., Slattery, M. L., Robison, L. M., French, T. K., and Mahoney, A. W. 1991. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control2:85-94.
45. Yamada, T., Nakamura, J., Murakami, M., Okuno, Y., Hosokawa, S., Matsuo, M., and Yamada, H. 1994. The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid. Toxicol. Appl. Pharmacol.129:146-154.
46. Yan, H., Carter, C. E., Xu, C., Singh, P. K., Jones, M. M., Johnson, J. E., and Dietrich, M. S. 1997. Cadmium-induced apoptosis in the urogenital organs of the male rat and its suppression by chelation. J. Toxicol. Environ. Health52:149-168.